Date Time
Ohio State University Tests New Gene Therapy Drug for Chronic Angina
COLUMBUS, Ohio – A new clinical trial at The Ohio State University Wexner Medical Center and Richard M. Ross Heart Hospital is using gene therapy in a new approach to help those suffering from chronic angina (chest pain) who can’t undergo stenting or coronary bypass surgery.
The Ohio State Wexner Medical Center is one of 11 sites nationwide and the only one in central Ohio to participate in this research, which provides hope for patients. Angina is chest pain or discomfort that happens when the heart doesn’t get as much blood and oxygen as it needs.
Ohio State to dedicate 25% of Wexner Medical Center's vaccines to students, staff 10tv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 10tv.com Daily Mail and Mail on Sunday newspapers.
Ohio State medical experts warn of impact from COVID-19 on the heart 10tv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 10tv.com Daily Mail and Mail on Sunday newspapers.
Updated: 4:33 PM EST January 27, 2021
COLUMBUS, Ohio Some might say candy can make you feel better by elevating your mood in certain situations, but scientists are putting it to an even more impactful use.
Researchers at Ohio State University are proposing that using hard candy to look for the loss of taste and smell in populations who are at risk of getting exposed to COVID-19 may help find probable cases of the virus in otherwise asymptomatic people.
The OSU research team got more than $300,000 to fund their study from the National Institutes of Health to figure out easier ways to identify people who have potentially contracted COVID-19.